MYELOSUPPRESSION

Adverse reaction reported in 52,642 FDA reports across 36 drugs.

52,642
Total Reports
36
Drugs Involved
Cyclophosphamide
Most Reported Drug

Drugs Associated with MYELOSUPPRESSION

Drugs where "MYELOSUPPRESSION" was reported as an adverse event.

# Drug Reports % of Total
1 Cyclophosphamide 4,137
7.9%
2 Cyclophosphamide For 4,137
7.9%
3 Carboplatin 3,512
6.7%
4 Paclitaxel 3,280
6.2%
5 Paclitaxel (Aibumin-Bound) 3,136
6.0%
6 Trastuzumab 2,911
5.5%
7 Cisplatin 2,486
4.7%
8 Venetoclax 2,438
4.6%
9 Docetaxel 2,146
4.1%
10 Cytarabine 2,088
4.0%
11 Bevacizumab 2,063
3.9%
12 Etoposide 1,855
3.5%
13 Oxaliplatin 1,611
3.1%
14 Dextrose 1,517
2.9%
15 Pertuzumab 1,485
2.8%
16 Azacitidine 1,467
2.8%
17 Doxorubicin 1,414
2.7%
18 Azacitidine For 1,358
2.6%
19 Fluorouracil 1,240
2.4%
20 Fluorouracil Cream, 0.5% 1,240
2.4%
21 Pemetrexed Disodium 816
1.6%
22 Vincristine 716
1.4%
23 Irinotecan 650
1.2%
24 Cetuximab 582
1.1%
25 Ifosfamide 518
1.0%
26 Obinutuzumab 500
0.9%
27 Abemaciclib 493
0.9%
28 Olaparib 411
0.8%
29 Pemetrexed 383
0.7%
30 Leucovorin 382
0.7%
31 Mercaptopurine 345
0.7%
32 Osimertinib 322
0.6%
33 Durvalumab 305
0.6%
34 Polatuzumab Vedotin 254
0.5%
35 Brentuximab Vedotin 238
0.5%
36 Fam-Trastuzumab Deruxtecan-Nxki 206
0.4%

Important Disclaimer

FDA adverse event reports are submitted voluntarily and do not prove causation. The presence of a drug in this list does not mean the drug caused myelosuppression. Always consult your healthcare provider.